Licensed medicines, off-label use or evidence-based. Which is most important?

Arch Dis Child. 2017 Jan;102(1):53-54. doi: 10.1136/archdischild-2016-311527. Epub 2016 Aug 17.

Authors

Maurizio Bonati¹, Evelyne Jacqz-Aigrain², Imti Choonara³

Affiliations

¹ Laboratory for Mother and Child Health, Department of Public Health, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
² Department of Paediatric Pharmacology and Pharmacogenetics, CIC1426 Inserm/APHP, University Paris Diderot, Robert Debre Hospital, Paris, France.
³ Academic Division of Child Health, University of Nottingham, Derbyshire Children's Hospital, Derby, UK.

PMID: 27535476
DOI: 10.1136/archdischild-2016-311527

No abstract available

Keywords: General Paediatrics; Paediatric Practice.

Publication types

Editorial
Comment

MeSH terms

Drug Approval*
Drug Labeling
Humans
Infant
Off-Label Use*